Antiviral Peptides Delivered by Chitosan-Based Nanoparticles to Neutralize SARS-CoV-2 and HCoV-OC43
The COVID-19 pandemic has made it clear that there is a crucial need for the design and development of antiviral agents that can efficiently reduce the fatality rate caused by infectious diseases. The fact that coronavirus mainly enters through the nasal epithelial cells and spreads through the nasa...
Saved in:
Main Authors: | Avinash Mali (Author), Gianluigi Franci (Author), Carla Zannella (Author), Annalisa Chianese (Author), Shubaash Anthiya (Author), Ana M. López-Estévez (Author), Alessandra Monti (Author), Anna De Filippis (Author), Nunzianna Doti (Author), María José Alonso (Author), Massimiliano Galdiero (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inhibition by components of Glycyrrhiza uralensis of 3CLpro and HCoV-OC43 proliferation
by: Jang Hoon Kim, et al.
Published: (2023) -
Inhibition of coronavirus HCoV-OC43 by targeting the eIF4F complex
by: Yongmei Feng, et al.
Published: (2022) -
Hylin-a1: A Host Defense Peptide with Antibacterial Potential against <i>Staphylococcus aureus</i> Multi-Resistant Strains
by: Annalisa Chianese, et al.
Published: (2023) -
The therapeutic promises of Lianhuaqingke in the mice model of coronavirus pneumonia (HCoV-229E and SARS-CoV-2)
by: Mingye Wang, et al.
Published: (2021) -
SARS-CoV-2 Fusion Peptide Conjugated to a Tetravalent Dendrimer Selectively Inhibits Viral Infection
by: Carla Zannella, et al.
Published: (2023)